The immune system is a complex organ that is often overlooked in the treatment of diseases.
But research shows that when the body is in a condition that makes it vulnerable to infections, it is able to fight back.
A group of researchers from the University of Florida and the University at Albany in New York found that by taking a multivitamin supplement, the immune system can boost the strength of its own body defenses and improve its ability to fight infections.
“When the body has to fight the infections, there’s an increase in the number of cells that are responding to the infection,” said Michael A. Dolan, a professor of medicine and of molecular medicine at the University College London.
“That increase in cells is a good thing.”
The study, published online today in Nature Medicine, was conducted in mice and showed that a multivalent form of the vitamin N-acetylcysteine (NAC), which has also been shown to help fight infections, increases the number and strength of immune cells in the body.
This was observed when researchers compared the mice treated with a supplement and those given a placebo.
The researchers found that mice that received the supplement had more immune cells than mice given a supplement.
“We think the vitamin supplements that we have on the market are working, but the reason why they work is because they work to help the immune cells to get activated,” said Dolan.
“This is what we call the pro-inflammatory response.”
Researchers have known for years that the body’s immune system, known as T-cells, can boost its own defenses against infections.
But it wasn’t clear how the body could get a boost in these T-cell production without the body producing antibodies to the virus or other microbes.
The new research found that this was the case.
The scientists used antibodies to monitor the production of T-cadherin, a molecule that is produced by the T-cycle, which is the precursor to T-lymphocytes, the type of cells involved in T-Cell response.
They found that T-Cadherins in mice treated the same way as the mice that were given the multivitamins and mice given the placebo had the same levels of Tcadh.
“There are different ways that antibodies can help to enhance immunity,” Dolan said.
“One of them is to bind to a receptor on the surface of a virus and then stimulate the T cells to produce antibodies.
So, if the T cell receptors are up, the virus can be killed.
And the Tc adherin protein in the T cadherina can also stimulate the production, so we think this is a way to stimulate T cells.”
The researchers also found that when they added the vitamin, NAC, to the mice, their immune systems were also boosted.
“The mice that had a high amount of T c adherins had increased levels of antibodies to Tc.
This is important because Tc can protect against infections,” Danko said.
The study is just the latest in a series of studies looking at the immune response and vitamin supplements.
In 2016, researchers from New York University found that taking a vitamin supplement could boost the immune responses of healthy people and those with conditions that cause inflammation.
And in 2017, researchers in the United Kingdom found that combining a multivalin, the antioxidant vitamin A, with vitamin E, a compound that fights free radicals, increased the immune reaction of mice.
But the multivalins are usually combined with a placebo and there is little research to show if they work together or if they need to be combined.
In 2018, researchers at the Mayo Clinic in Rochester, Minnesota, found that a vitamin or mineral supplement made with a combination of minerals could help to boost the levels of immune responses in healthy people.
And last year, a study led by a team from Yale University found a combination vitamin C, B6 and vitamin E had the potential to boost immune response in mice.
“A lot of people have asked us whether or not we can combine them to make a multivan,” Dansky said.
So far, Dansky and his team haven’t seen any positive studies.
Dansky hopes that by studying the effects of vitamin supplements on the immune systems of people with certain types of cancer, he and his colleagues will have a better idea of how to use them.
“What we are hoping is that this is the first step toward a better understanding of what the mechanism is,” he said.